(1 - 19 from 22
)
Delphi Diagnostics SET2,3 Test Clarifies Therapy Options for …
www.precisiononcologynews.com
· SET2,3 and SET ER/PR were developed at MD Anderson Cancer Center by Fraser Symmans, a professor of pathology. Both have been licensed to Houston, Texas-based Delphi Diagnostics, where they are in advanced stages of development in preparation for …
W. Fraser Symmans – The Katy Newsthekatynews.com › tag › w-fraser-symmans
thekatynews.com
The study's results were presented by W. Fraser Symmans, M.D., professor of Pathology, during the San Antonio Breast Cancer ...
Genomic Test Shows Promise as Predictor of Chemotherapy...
www.mdanderson.org
... breast cancer who are candidates for chemotherapy,” says W. Fraser Symmans, M.D., professor in MD Anderson's Department of Pathology.
Pathology and Laboratory Medicine Special Lecture - Weill ...events.weill.cornell.edu › event › pathology_and_laborat...
events.weill.cornell.edu
W. Fraser Symmans, MB, ChB Professor of Pathology and Translational Molecular Pathology Director of Research Operations, Department of Pathology Director ...
sorted by relevance / date